DengYueMed is a global pharmaceutical intelligence and distribution-oriented platform focused on oncology and rare disease markets.

As China’s pharmaceutical industry transitions from a generics-driven participant to an innovation-driven contributor, the global healthcare landscape is entering a new multipolar era.

DengYueMed was established to document, interpret, and support this transformation — connecting Chinese pharmaceutical advancement with global medical accessibility.